Holen Sie sich die Stockscreener-App
1.17
2.50%
-0.03
Vorhandelsmarkt:
1.17
Schlusskurs vom Vortag:
$1.20
Offen:
$1.19
24-Stunden-Volumen:
53,039
Relative Volume:
0.04
Marktkapitalisierung:
$12.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-15.83%
1M Leistung:
-15.22%
6M Leistung:
-43.48%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.15
$1.1982
1-Wochen-Bereich:
$1.15
$1.37
52-Wochen-Spanne:
$0.7701
$5.50
Gelteq Ltd Stock (GELS) Company Profile
Vergleichen Sie GELS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.17 | 12.03M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 |
Gelteq Ltd Aktie (GELS) Neueste Nachrichten
Will Gelteq Limited stock continue dividend increases2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Key metrics from Gelteq Limited’s quarterly dataQuarterly Profit Summary & AI Enhanced Trade Execution Alerts - newser.com
How moving averages guide Gelteq Limited tradingAnalyst Upgrade & Proven Capital Preservation Tips - newser.com
What margin trends mean for Gelteq Limited stockWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Will Gelteq Limited stock reach all time highs in 2025July 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform - MSN
Will Gelteq Limited stock continue upward momentumTrade Entry Report & Low Risk Investment Opportunities - Fundação Cultural do Pará
Is Gelteq Limited stock supported by strong fundamentals2025 Technical Overview & Growth Focused Stock Reports - newser.com
Is Gelteq Limited stock near bottom after decline2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
Market reaction to Gelteq Limited’s recent newsOil Prices & Real-Time Stock Entry Alerts - newser.com
What technical models suggest about Gelteq Limited’s comebackEarnings Trend Report & Real-Time Market Sentiment Alerts - newser.com
Real time pattern detection on Gelteq Limited stockTrade Risk Summary & Daily Technical Forecast Reports - newser.com
Is Gelteq Limited stock dividend yield sustainableWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Gelteq (GELS) starts preclinical trial with Monash for oily, poorly soluble drugs - Stock Titan
Using portfolio simulators with Gelteq Limited includedWeekly Volume Report & Smart Money Movement Alerts - newser.com
Published on: 2025-10-21 21:31:20 - newser.com
Investment Review: How Gelteq Limited stock performs in interest rate cycles2025 Investor Takeaways & Community Shared Stock Ideas - Trung tâm Dự báo KTTV quốc gia
What analyst consensus says on Gelteq Limited stock2025 Retail Activity & Low Drawdown Momentum Ideas - Trung tâm Dự báo KTTV quốc gia
Is Gelteq Limited stock a buy on dips2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - Trung tâm Dự báo KTTV quốc gia
How Gelteq Limited stock performs in interest rate cyclesLong Setup & AI Powered Market Entry Strategies - Trung tâm Dự báo KTTV quốc gia
Published on: 2025-10-18 12:21:43 - Trung tâm Dự báo KTTV quốc gia
Can Gelteq Limited stock sustain institutional interest2025 Historical Comparison & Expert Curated Trade Setups - Trung tâm Dự báo KTTV quốc gia
Is Gelteq Limited stock ready for a breakout2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Gelteq Limited (GELS) Stock Price, News, Quote & History - Yahoo
Gelteq Limited (GELS) Latest Press Releases & Corporate News - Yahoo
Gelteq partners with Melbourne Health to develop bowel cancer prevention gel - Investing.com India
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - The Manila Times
HAMSB product development: Gelteq and Melbourne Health partner to target bowel polyp growth reduction - Stock Titan
What moving averages say about Gelteq LimitedJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
Using Python tools to backtest Gelteq Limited strategiesMarket Movers & Long-Term Growth Plans - newser.com
Does Gelteq Limited fit your quant trading modelQuarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will Gelteq Limited stock deliver better than expected guidance2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Can Gelteq Limited hit a new high this monthGold Moves & Free Safe Entry Trade Signal Reports - newser.com
Risk vs reward if holding onto Gelteq LimitedQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
Finanzdaten der Gelteq Ltd-Aktie (GELS)
Es liegen keine Finanzdaten für Gelteq Ltd (GELS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.51%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):